| Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia G Skibinski, NJ Parkinson, JM Brown, L Chakrabarti, SL Lloyd, ... Nature genetics 37 (8), 806-808, 2005 | 930 | 2005 |
| Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ K Nakamura, VM Nemani, F Azarbal, G Skibinski, JM Levy, K Egami, ... Journal of Biological Chemistry 286 (23), 20710-20726, 2011 | 620 | 2011 |
| Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis SJ Barmada, G Skibinski, E Korb, EJ Rao, JY Wu, S Finkbeiner Journal of Neuroscience 30 (2), 639-649, 2010 | 511 | 2010 |
| ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) N Parkinson, PG Ince, MO Smith, R Highley, G Skibinski, PM Andersen, ... Neurology 67 (6), 1074-1077, 2006 | 491 | 2006 |
| In silico labeling: predicting fluorescent labels in unlabeled images EM Christiansen, SJ Yang, DM Ando, A Javaherian, G Skibinski, S Lipnick, ... Cell 173 (3), 792-803. e19, 2018 | 457 | 2018 |
| Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies G Skibinski, K Nakamura, MR Cookson, S Finkbeiner Journal of Neuroscience 34 (2), 418-433, 2014 | 148 | 2014 |
| Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson’s disease G Toth, SJ Gardai, W Zago, CW Bertoncini, N Cremades, SL Roy, ... PloS one 9 (2), e87133, 2014 | 141 | 2014 |
| Nrf2 mitigates LRRK2-and α-synuclein–induced neurodegeneration by modulating proteostasis G Skibinski, V Hwang, DM Ando, A Daub, AK Lee, A Ravisankar, ... Proceedings of the National Academy of Sciences 114 (5), 1165-1170, 2017 | 99 | 2017 |
| iPS cells in the study of PD molecular pathogenesis MM Cobb, A Ravisankar, G Skibinski, S Finkbeiner Cell and tissue research 373, 61-77, 2018 | 33 | 2018 |
| Drug discovery in Parkinson’s disease—Update and developments in the use of cellular models G Skibinski, S Finkbeiner International journal of high throughput screening 2011 (2), 15, 2011 | 33 | 2011 |
| Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease G Skibinski, S Finkbeiner FEBS letters 587 (8), 1139-1146, 2013 | 19 | 2013 |
| MRC Proteomics in ALS Study; FReJA Consortium (2006) N Parkinson, PG Ince, MO Smith, R Highley, G Skibinski, PM Andersen, ... ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein …, 2006 | 19 | 2006 |
| Frontotemporal dementia linked to chromosome 3 J Brown, S Gydesen, P Johannsen, A Gade, G Skibinski, L Chakrabarti, ... Dementia and geriatric cognitive disorders 17 (4), 274-276, 2004 | 11 | 2004 |
| The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity AED Stormo, F Shavarebi, M FitzGibbon, EM Earley, H Ahrendt, LS Lum, ... Journal of Cell Biology 221 (4), 2022 | 7 | 2022 |
| Optimization and scaling of patient-derived brain organoids uncovers deep phenotypes of disease K Shah, R Bedi, A Rogozhnikov, P Ramkumar, Z Tong, B Rash, M Stanton, ... bioRxiv, 2020.08. 26.251611, 2020 | 7 | 2020 |
| A three‐groups model for high‐throughput survival screens BA Shaby, G Skibinski, M Ando, ES LaDow, S Finkbeiner Biometrics 72 (3), 936-944, 2016 | 6 | 2016 |
| Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006) G Novak, S Finkbeiner, G Skibinski, A Skupin Stem Cell Research 57, 102569, 2021 | 2 | 2021 |
| Preclinical signs of impairment in persons at high risk of frontotemporal dementia related to chromosome 3 (FTD3): Preliminary findings in neuropsychological tests A Gade, G Skibinski, S Gydesen Neurobiol Aging 25 (suppl 2), S453, 2004 | 2 | 2004 |
| Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W … G Novak, S Finkbeiner, G Skibinski, M Bernini, C Donato, A Skupin Stem Cell Research 61, 102765, 2022 | 1 | 2022 |
| Mutations in the endosomal ESCRTIII complex subunit CHMP2B in frontotemporal dementia G Skibinski, N Parkinson, E Fisher, J Collinge, Freja Consortium CAMBRIDGE UNIV PRESS 88 (1), 75-76, 2006 | 1 | 2006 |
